Mon, 2 Feb 2026

 

Nanyah: FMC denies negligence over singer’s death, says claims of non-availability of anti-snake venom unfounded
 
By: Abara Blessing Oluchi
Mon, 2 Feb 2026   ||   Nigeria,
 

The management of the Federal Medical Centre (FMC), Jabi, says efforts were made to save the life of singer Ifunanya Nwagene, popularly known as Nanyah, who died from a snake bite.

The hospital denied allegations on social media that it failed to provide adequate care to Ifunanya, who suffered complications from the bite.

“Our team of professionals worked diligently to provide CPR and other life-saving measures; however, despite these efforts, we were unable to revive her,” the hospital said in a statement on Sunday.

According to the statement, doctors quickly assessed the patient and established that she had developed serious neurotoxic complications from the snake bite.

The hospital added that arrangements were already being made to transfer her to the Intensive Care Unit (ICU) when her condition suddenly worsened.

“Despite all efforts to stabilise her condition and transfer her to the ICU for further treatment, she experienced a sudden deterioration just before the transfer.

“Our medical staff provided immediate and appropriate treatment, including resuscitation efforts, intravenous fluids, intranasal oxygen, and the administration of polyvalent snake antivenom,” the statement said.

According to the statement, the singer died from severe neurotoxic complications arising from the snake bite, and not from negligence or the absence of anti-snake venom, as alleged online.

FMC expressed sympathy with the family of the deceased, describing her death as a painful loss.

“First and foremost, we express our deepest condolences to the Nwagene family during this incredibly difficult time.

“After a thorough but quick evaluation, it was clear that Ms. Nwagene suffered severe neurotoxic complications from the snake bite.

“We stand by the quality of care and dedication our team demonstrates daily. The claims of non-availability of anti-snake venom and inadequate response are unfounded and do not reflect the reality of the situation. We are committed to transparency and integrity in our practices and will continue to pursue excellence in patient care,” the statement added.

 

Tag(s):
 
 
Back to News